Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res. 2014 Jun 15; 20(12):3280-8.